These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 3136331)
1. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. Sima AA; Bril V; Nathaniel V; McEwen TA; Brown MB; Lattimer SA; Greene DA N Engl J Med; 1988 Sep; 319(9):548-55. PubMed ID: 3136331 [TBL] [Abstract][Full Text] [Related]
2. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330 [TBL] [Abstract][Full Text] [Related]
3. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)]. Christensen JE; Larsen AB; Gregersen G Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975 [No Abstract] [Full Text] [Related]
4. Overt diabetic neuropathy: repair of axo-glial dysjunction and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity. Sima AA; Prashar A; Nathaniel V; Bril V; Werb MR; Greene DA Diabet Med; 1993 Mar; 10(2):115-21. PubMed ID: 8458187 [TBL] [Abstract][Full Text] [Related]
5. Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes. Jaspan JB; Towle VL; Maselli R; Herold K Metabolism; 1986 Apr; 35(4 Suppl 1):83-92. PubMed ID: 3083212 [TBL] [Abstract][Full Text] [Related]
6. Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy. Jaspan JB; Herold K; Bartkus C Am J Med; 1985 Nov; 79(5A):24-37. PubMed ID: 3000176 [TBL] [Abstract][Full Text] [Related]
7. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors. Jacobson M; Sharma YR; Cotlier E; Hollander JD Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448 [TBL] [Abstract][Full Text] [Related]
8. Six-month treatment with sorbinil in asymptomatic diabetic neuropathy. Failure to improve abnormal nerve function. Martyn CN; Reid W; Young RJ; Ewing DJ; Clarke BF Diabetes; 1987 Sep; 36(9):987-90. PubMed ID: 3111914 [TBL] [Abstract][Full Text] [Related]
9. Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group. Sima AA; Greene DA; Brown MB; Hohman TC; Hicks D; Graepel GJ; Bochenek WJ; Beg M; Gonen B J Diabetes Complications; 1993; 7(3):157-69. PubMed ID: 8343610 [TBL] [Abstract][Full Text] [Related]
10. Aldose reductase inhibitors and late complications of diabetes. Benfield P Drugs; 1986; 32 Suppl 2():43-55. PubMed ID: 3098544 [TBL] [Abstract][Full Text] [Related]
11. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. Obrosova IG; Van Huysen C; Fathallah L; Cao XC; Greene DA; Stevens MJ FASEB J; 2002 Jan; 16(1):123-5. PubMed ID: 11709499 [TBL] [Abstract][Full Text] [Related]
12. Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year's treatment with sorbinil. O'Hare JP; Morgan MH; Alden P; Chissel S; O'Brien IA; Corrall RJ Diabet Med; 1988 Sep; 5(6):537-42. PubMed ID: 2974776 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of aldose reductase in human diabetic neuropathy. Jaspan J Drugs; 1986; 32 Suppl 2():23-9. PubMed ID: 2431859 [TBL] [Abstract][Full Text] [Related]
15. Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy. Lewin IG; O'Brien IA; Morgan MH; Corrall RJ Diabetologia; 1984 Jun; 26(6):445-8. PubMed ID: 6432615 [TBL] [Abstract][Full Text] [Related]
16. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats. Yue DK; Hanwell MA; Satchell PM; Turtle JR Diabetes; 1982 Sep; 31(9):789-94. PubMed ID: 6819173 [TBL] [Abstract][Full Text] [Related]
17. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats. Yagihashi S; Kamijo M; Ido Y; Mirrlees DJ Diabetes; 1990 Jun; 39(6):690-6. PubMed ID: 2140802 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor. Greene DA; Lattimer SA Am J Med; 1985 Nov; 79(5A):13-7. PubMed ID: 3000175 [TBL] [Abstract][Full Text] [Related]